Related by context. Frequent words. (Click for all words.) 80 Patient Enrollment 78 Drug Candidate 78 Generic Version 76 Clinical Trial Results 76 Phase III Trial 75 Presents Positive 75 Phase III Clinical Trial 75 Completes Enrollment 75 Cholesterol Drug 75 FDA Clears 73 Preclinical Data 73 FDA Accepts 72 FDA Clearance 72 Patent Covering 72 Blood Thinner 72 BioDelivery Sciences 71 Well Tolerated 71 #.#/Share [002] 71 Prostate Cancer Patients 71 Pivotal Phase III 71 Announces Initiation 71 RNAi Therapeutics 71 Achieves Milestone 71 Positive Opinion 70 Pulmonary Arterial Hypertension 70 Cervical Cancer Vaccine 70 Pivotal Trial 70 Small Molecule 70 Receives FDA Clearance 70 Cancer Treatments 70 Smallpox Vaccine 70 Diet Pill 70 Exclusive License 70 Pivotal Phase 70 Metastatic Melanoma 70 Commercialization Agreement 70 Patent Lawsuit 70 Monoclonal Antibody 69 FY# Guidance 69 Share Repurchases 69 Stock Buyback 69 ACADIA Pharmaceuticals 69 Bird Flu Vaccine 69 Previously Announced 69 Inc Therapeutic Competitors 69 Advanced Prostate Cancer 68 Initiates Phase 68 Study Demonstrates 68 Patent Issued 68 Significantly Reduces 68 Low Dose 68 Q3 Loss Narrows 68 Completes Tender Offer 68 Share Buyback 67 Reduces Risk 67 Guidance Quick Facts 67 Q1 Loss Narrows 67 4Q Loss Widens 67 Q2 Loss Narrows 67 Licensing Agreements 67 FDA Approves 67 Option Grants 67 Posts Wider Loss 67 Anika Therapeutics 67 Annual Meeting Date 67 Elderly Patients 67 Flu Vaccines 67 Updates Guidance 67 Extends Tender Offer 67 Revenues Decline 67 Net Loss Narrows 67 Successful Completion 67 Patent Infringement Case 67 Commercialize 67 Reaffirms Guidance 67 Explore Strategic Alternatives 67 Patients Treated 67 Combination Therapy 67 Licensing Deal 67 Epratuzumab 67 Chronic Hepatitis C 67 Patent Infringement Lawsuit 66 Q3 Loss Widens 66 Metastatic Colorectal Cancer 66 Q2 Loss Widens 66 Q4 Loss Narrows 66 Q1 Loss Widens 66 Breast Cancer Treatment 66 Record Second Quarter 66 Revenue Grows 66 Shows Promise 66 Sunesis Pharmaceuticals 66 Record Third Quarter 66 Vertex Pharmaceuticals Announces 66 Malaria Vaccine 66 Receives Patent 66 Cost Reductions 66 Anthrax Vaccine 66 Q4 Loss Widens 66 Secures Additional 66 Heart Failure Patients